64 related articles for article (PubMed ID: 38674250)
1. Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas.
Araujo-Castro M; Pascual-Corrales E; Lorca Álvaro J; Mínguez Ojeda C; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Serrano Romero AB; Alonso-Gordoa T; Molina-Cerrillo J; Gómez Dos Santos V
Actas Urol Esp (Engl Ed); 2023 Mar; 47(2):68-77. PubMed ID: 37078847
[TBL] [Abstract][Full Text] [Related]
2. Management of Abdominal Paraganglioma: A Single Center's Experience.
Battistella E; Pomba L; Mirabella M; Toniato R; Opocher G; Toniato A
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674250
[No Abstract] [Full Text] [Related]
3. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE).
Jalil ND; Pattou FN; Combemale F; Chapuis Y; Henry JF; Peix JL; Proye CA
Eur J Surg; 1998 Jan; 164(1):23-8. PubMed ID: 9537705
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
[TBL] [Abstract][Full Text] [Related]
5. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Jing H; Li F; Wang L; Wang Z; Li W; Huo L; Zhang J
Clin Nucl Med; 2017 Jul; 42(7):525-529. PubMed ID: 28481789
[TBL] [Abstract][Full Text] [Related]
8. Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review.
Wang X; Zhao Y; Liao Z; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1129622. PubMed ID: 37152961
[TBL] [Abstract][Full Text] [Related]
9. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
Lima JV; Kater CE
Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
[TBL] [Abstract][Full Text] [Related]
10. Advances in Endocrine Surgery.
Lui MS; Shirali AS; Huang BL; Fisher SB; Perrier ND
Surg Oncol Clin N Am; 2023 Jan; 32(1):199-220. PubMed ID: 36410918
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Shah MH; Goldner WS; Benson AB; Bergsland E; Blaszkowsky LS; Brock P; Chan J; Das S; Dickson PV; Fanta P; Giordano T; Halfdanarson TR; Halperin D; He J; Heaney A; Heslin MJ; Kandeel F; Kardan A; Khan SA; Kuvshinoff BW; Lieu C; Miller K; Pillarisetty VG; Reidy D; Salgado SA; Shaheen S; Soares HP; Soulen MC; Strosberg JR; Sussman CR; Trikalinos NA; Uboha NA; Vijayvergia N; Wong T; Lynn B; Hochstetler C
J Natl Compr Canc Netw; 2021 Jul; 19(7):839-868. PubMed ID: 34340212
[TBL] [Abstract][Full Text] [Related]
13. Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.
Araujo-Castro M; Pascual-Corrales E; Nattero Chavez L; Martínez Lorca A; Alonso-Gordoa T; Molina-Cerrillo J; Lorca Álvaro J; Mínguez Ojeda C; Redondo López S; Barberá Durbán R; Polo López R; Moreno Mata N; Caballero Silva U; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Gómez Dos Santos V; Serrano Romero AB
J Endocrinol Invest; 2021 Dec; 44(12):2545-2555. PubMed ID: 34304388
[TBL] [Abstract][Full Text] [Related]
14. Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
